Webinars and Events | August 9, 2022

SFA: Solvency Through 2051?

The multiemployer Special Financial Assistance (SFA) program, which was part of the American Rescue Plan Act passed by Congress in March 2021, is intended to enable eligible deeply troubled plans to pay all benefits and expenses due through 2051. Interim PBGC rules drew considerable criticism from a wide variety of stakeholders. Final regulations recently issued by PBGC respond to those concerns. Although the final rules primarily affect eligible plans that apply for SFA, there are also implications for some plans that may have not considered SFA.

Woman Two Men Walk Under Scaffold At Construction Site

On August 9, our actuarial, compliance and investment advisory experts discussed the considerations for plan sponsors resulting from the PBGC’s final rule, including:

  • Changes to calculating the amount of SFA: impact of a dual interest rate approach
  • Special consideration of plans that suspended benefits under the Multiemployer Pension Reform Act of 2014
  • Application timing: changes to and “locking in” of the measurement date; filing of a supplemental application
  • Restrictions imposed on plans that receive SFA: mergers, withdrawal liability, contribution rates, benefit improvements
  • Expansion of permissible investments; implications for asset mix and solvency
  • Review of the limitations for both the return seeking assets and remaining SFA assets

Watch the Replay

 

Presenters

Moderator: Eli Greenblum, SVP and Chief Actuary

Panelists:

  • Susan Boyle, SVP, Actuary and Multiemployer Retirement Practice Leader
  • Beth Bangert, SVP, National Retirement Compliance
  • TJ Kistner, VP, Head of Discretionary Portfolio Management & Solutions

Get the Slides

Don’t have time to watch a video right now? No worries. Here is a copy of the slides.

Download Now

See our insights

Arab Couple Smiling And Doing Their Finances

Employees' Financial Well-Being Matters to Them and Your ROI

Learn how a financial well-being program can help your people and your bottom line ― and how to use a scorecard to ensure that it’s working.
Lab Technicians

Spotlight on Gene Therapies in Q2 2024 Trends

Health plan sponsors: Ready for gene therapies? We explore four solutions that support reimbursement and patient access to these high-cost treatments.
Male Doctor Checking Senior Female Patient And Smiling

Implications of Coming Medicare Part D Changes for Retiree Health Plans

Watch a webinar on the Inflation Reduction Act’s coming Medicare Part D changes and the 2025 impact on retiree health plan sponsors with EGWPs.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.